Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alawi A Alsheikh-Ali

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|June 14, 2008
The safety of niacin in the US Food and Drug Administration adverse event reporting databaseAlawi A Alsheikh-Ali, Richard H Karas
Preventive Cardiology|April 30, 2005
Adverse events with concomitant amiodarone and statin therapyAlawi A Alsheikh-Ali, Richard H Karas
Current Atherosclerosis Reports|February 21, 2009
The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trialsAlawi A Alsheikh-Ali, Richard H Karas
BMJ (Clinical Research Ed.)|May 22, 2010
Balancing the intended and unintended effects of statinsAlawi A Alsheikh-Ali, Richard H Karas
Journal of Clinical Lipidology|February 5, 2011
Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysisAlawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|May 29, 2004
Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinedionesAlawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|January 31, 2007
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system)Alawi A Alsheikh-Ali, Richard H Karas
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Anticoagulation control in atrial fibrillation: optimizing risks and benefitsAlawi A Alsheikh-Ali, N A Mark Estes
Annals of Internal Medicine|December 22, 2010
Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular riskHaseeb Jafri, Alawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|December 26, 2007
Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin useNoa Holoshitz, Alawi A Alsheikh-Ali, Richard H Karas
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|June 14, 2008
The safety of niacin in the US Food and Drug Administration adverse event reporting databaseAlawi A Alsheikh-Ali, Richard H Karas
Preventive Cardiology|April 30, 2005
Adverse events with concomitant amiodarone and statin therapyAlawi A Alsheikh-Ali, Richard H Karas
Current Atherosclerosis Reports|February 21, 2009
The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trialsAlawi A Alsheikh-Ali, Richard H Karas
BMJ (Clinical Research Ed.)|May 22, 2010
Balancing the intended and unintended effects of statinsAlawi A Alsheikh-Ali, Richard H Karas
Journal of Clinical Lipidology|February 5, 2011
Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysisAlawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|May 29, 2004
Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinedionesAlawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|January 31, 2007
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system)Alawi A Alsheikh-Ali, Richard H Karas
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Anticoagulation control in atrial fibrillation: optimizing risks and benefitsAlawi A Alsheikh-Ali, N A Mark Estes
Annals of Internal Medicine|December 22, 2010
Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular riskHaseeb Jafri, Alawi A Alsheikh-Ali, Richard H Karas
The American Journal of Cardiology|December 26, 2007
Relative safety of gemfibrozil and fenofibrate in the absence of concomitant cerivastatin useNoa Holoshitz, Alawi A Alsheikh-Ali, Richard H Karas
Pageof 15